• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.

作者信息

Davis S R

出版信息

J Clin Endocrinol Metab. 1997 Feb;82(2):702-3. doi: 10.1210/jcem.82.2.3771-3.

DOI:10.1210/jcem.82.2.3771-3
PMID:9024281
Abstract
摘要

相似文献

1
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.“补充性”雌激素可逆转促性腺激素释放激素激动剂诱发的子宫平滑肌瘤女性的认知缺陷。
J Clin Endocrinol Metab. 1997 Feb;82(2):702-3. doi: 10.1210/jcem.82.2.3771-3.
2
A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.一项针对子宫平滑肌瘤女性的促性腺激素释放激素激动剂联合雌激素 - 孕激素或孕激素“反加”方案的前瞻性随机试验。
J Clin Endocrinol Metab. 1993 Jun;76(6):1439-45. doi: 10.1210/jcem.76.6.8501148.
3
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri.
J Clin Endocrinol Metab. 1996 Jul;81(7):2545-9. doi: 10.1210/jcem.81.7.8675575.
4
Regulation of dosage of conjugated equine estrogen is useful for add-back therapy.
J Med. 2000;31(3-4):167-75.
5
Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function.单次或重复使用促性腺激素释放激素激动剂治疗可避免对患有有症状的大子宫肌瘤的绝经前妇女进行子宫切除术，且对性功能无影响。
J Obstet Gynaecol Res. 2014 Jan;40(1):117-24. doi: 10.1111/jog.12135. Epub 2013 Sep 5.
6
Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.在促性腺激素释放激素激动剂治疗下，类固醇补充疗法对子宫平滑肌瘤细胞增殖活性的影响。
Gynecol Endocrinol. 2005 Feb;20(2):80-3. doi: 10.1080/09513590400021029.
7
Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
Fertil Steril. 1995 Oct;64(4):673-85. doi: 10.1016/s0015-0282(16)57837-6.
8
Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist.一名年轻女性在接受促黄体生成素释放激素激动剂治疗期间，子宫平滑肌肉瘤与富于细胞性非典型平滑肌瘤共存。
Gynecol Oncol. 1994 Jan;52(1):74-9. doi: 10.1006/gyno.1994.1014.
9
[GnRH analogues in the management of uterine leiomyoma].[促性腺激素释放激素类似物在子宫平滑肌瘤治疗中的应用]
Nihon Rinsho. 2006 Apr;64 Suppl 4:75-9.
10
Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata.促性腺激素释放激素激动剂治疗子宫肌瘤后血浆血管内皮生长因子水平升高。
Gynecol Endocrinol. 2008 Dec;24(12):724-6. doi: 10.1080/09513590802454901.